#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Ireland Italy The Netherlands Poland +1

  • A study to evaluate the safety and effectiveness of AZD9750 and saruparib in patients with metastatic prostate cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Spain

  • A study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain

  • A study testing the safety and effectiveness of AZD0516 alone and with other cancer drugs in adults with metastatic prostate cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Poland Spain

  • A Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Finland France Germany +6

  • Safety Study of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Patients with Metastatic Colorectal or Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of Darolutamide and Testosterone for Patients with Advanced Prostate Cancer Resistant to Standard Hormone Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Denmark France Germany Greece +7

  • Study on Re-treatment with Lutetium (177Lu) Vipivotide Tetraxetan for Men with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Effect of Degarelix on Prostate-Specific Membrane Antigen in Patients with Untreated Metastatic Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland